LTRN Lantern Pharma Inc.
15.3
-0.43 -3%
Previous Close
15.73
Open
15.69
52 Week Low
10.4
52 Week High
24.84
Market Cap
$95,128,928
Shares
6,217,577
Float
2,301,815
Enterprise Value
$79,098,068
Volume
22,965
Av. Daily Volume
33,609
Drug Pipeline
| Drug | Stage | Notes |
|---|---|---|
|
LP-300
Non-small cell lung cancer (NSCLC)
|
Phase 2
Phase 2
|
Phase 2 trial planned.
|
|
LP-100
Hormone-refractory prostate cancer (MHRPC)
|
Phase 2
Phase 2
|
Phase 2 trial ongoing.
|